---
figid: PMC5983605__ijms-19-01543-g002
figtitle: Diagram of WNT (Wingless-type) signaling pathway
organisms:
- NA
pmcid: PMC5983605
filename: ijms-19-01543-g002.jpg
figlink: /pmc/articles/PMC5983605/figure/ijms-19-01543-f002/
number: F2
caption: 'Diagram of WNT (Wingless-type) signaling pathway. OMP-54F28 and sFZD7 act
  as decoy receptors to reduce the binding of ligands and receptors. The anti-FZD
  antibody binds to the conserved epitope of extracellular domain of FZDs to form
  a ligand-receptor complex, preventing the WNT ligands from interacting with FZDs.
  The small molecule compound SRI37892 targets the transmembrane of FZD7 and block
  WNT signal transmission. Small interfering peptides RHPDs (Rhodamine-tagged heptapeptide
  protein transduction domain for binding DVL) and Small molecule inhibitor FJ9 disrupt
  the joint of FZD7 and DVL. The DVL is not activated so that the WNT signal is unable
  to be transmitted into the cell. Abbreviations: FZDAb: FZD antibodies; CK1: casein
  kinase 1; APC: adenomatous polyposis coli; GSK3β: glycogen synthase kinase-3β; DVL:
  Dishevelled.'
papertitle: Frizzled Receptors as Potential Therapeutic Targets in Human Cancers.
reftext: Chui-Mian Zeng, et al. Int J Mol Sci. 2018 May;19(5):1543.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9766648
figid_alias: PMC5983605__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5983605__F2
ndex: 1975c33a-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5983605__ijms-19-01543-g002.html
  '@type': Dataset
  description: 'Diagram of WNT (Wingless-type) signaling pathway. OMP-54F28 and sFZD7
    act as decoy receptors to reduce the binding of ligands and receptors. The anti-FZD
    antibody binds to the conserved epitope of extracellular domain of FZDs to form
    a ligand-receptor complex, preventing the WNT ligands from interacting with FZDs.
    The small molecule compound SRI37892 targets the transmembrane of FZD7 and block
    WNT signal transmission. Small interfering peptides RHPDs (Rhodamine-tagged heptapeptide
    protein transduction domain for binding DVL) and Small molecule inhibitor FJ9
    disrupt the joint of FZD7 and DVL. The DVL is not activated so that the WNT signal
    is unable to be transmitted into the cell. Abbreviations: FZDAb: FZD antibodies;
    CK1: casein kinase 1; APC: adenomatous polyposis coli; GSK3β: glycogen synthase
    kinase-3β; DVL: Dishevelled.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - APP
  - SUCLA2
  - LRP6
  - LRP5
  - AN
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - GSK3B
  - CTNNB1
---
